- Home
- ENOV vs ALTM Comparison
ENOV vs ALTM Comparison
Compare ENOV & ALTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- ALTM
- Stock Information
- Founded
- ENOV 1995
- ALTM 1942
- Country
- ENOV United States
- ALTM Ireland
- Employees
- ENOV N/A
- ALTM N/A
- Industry
- ENOV Fluid Controls
- ALTM
- Sector
- ENOV Industrials
- ALTM
- Exchange
- ENOV Nasdaq
- ALTM Nasdaq
- Market Cap
- ENOV 2.7B
- ALTM 2.6B
- IPO Year
- ENOV 2008
- ALTM N/A
- Fundamental
- Price
- ENOV $45.19
- ALTM $5.03
- Analyst Decision
- ENOV Strong Buy
- ALTM Hold
- Analyst Count
- ENOV 10
- ALTM 17
- Target Price
- ENOV $67.44
- ALTM $5.51
- AVG Volume (30 Days)
- ENOV 539.9K
- ALTM 8.9M
- Earning Date
- ENOV 11-06-2024
- ALTM 11-07-2024
- Dividend Yield
- ENOV N/A
- ALTM N/A
- EPS Growth
- ENOV N/A
- ALTM N/A
- EPS
- ENOV N/A
- ALTM 0.16
- Revenue
- ENOV $2,001,668,000.00
- ALTM $900,600,000.00
- Revenue This Year
- ENOV $25.59
- ALTM $15.47
- Revenue Next Year
- ENOV $5.97
- ALTM $20.61
- P/E Ratio
- ENOV N/A
- ALTM $32.49
- Revenue Growth
- ENOV 20.52
- ALTM N/A
- 52 Week Low
- ENOV $38.27
- ALTM $2.19
- 52 Week High
- ENOV $65.03
- ALTM $7.80
- Technical
- Relative Strength Index (RSI)
- ENOV 46.97
- ALTM 45.45
- Support Level
- ENOV $45.03
- ALTM $5.10
- Resistance Level
- ENOV $47.04
- ALTM $5.23
- Average True Range (ATR)
- ENOV 1.13
- ALTM 0.10
- MACD
- ENOV -0.44
- ALTM -0.03
- Stochastic Oscillator
- ENOV 18.27
- ALTM 34.38
About ENOV Enovis Corporation
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
About ALTM Arcadium Lithium plc
Arcadium Lithium is a pure-play lithium producer that was formed in the Allkem-Livent merger in January 2024. Arcadium should benefit from increased lithium demand via higher electric vehicle adoption, as lithium is a key component of EV batteries. The company's low-cost lithium carbonate production comes from two brine resources in Argentina. Arcadium also produces spodumene, a hard rock lithium upstream concentrate, from a mine in Australia and operates downstream lithium hydroxide conversion plants in the United States and China.